Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03010826
Other study ID # 1000053920
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 2016
Est. completion date November 16, 2018

Study information

Verified date January 2020
Source The Hospital for Sick Children
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The neural circuits in our brains require a layer of insulation in order to transmit signals in a rapid and efficient fashion. This insulation is called White Matter and is comprised of a specific type of brain cell called an oligodendrocytes. Damage to brain white matter occurs following injury and in disorders like Multiple Sclerosis and results in sensory, motor, and cognitive problems. Currently there are no effective medical therapies to promote brain repair and reduce disability following damage to white matter. In this project, we hope to change the situation by encouraging the brain itself to generate new oligodendrocytes and thus new white matter. Our first step is to find measures sensitive to white matter growth.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date November 16, 2018
Est. primary completion date November 16, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 18 Years
Eligibility Inclusion Criteria:

- Experienced a demyelinating event (Only applicable to patient subjects)

- Between the ages of 5 years to 18 years and 11 months of age

- Has either English as his or her native language or has had at least two years of schooling in English

Exclusion Criteria:

- Children with non-demyelinating etiologies of white matter dysfunction (i.e., metabolic disorders, vasculitis, and non-specific MRI abnormalities

- Is younger than 5 years of age

- Is 18 years and 11 of age or older

- Has a prior history of traumatic brain injury, neurological disorder, cerebral palsy, developmental delay, or learning disability

- Requires sedation for brain scanning

- Is claustrophobic, as brain scanning requires children to enter a tunnel in the MRI machine

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Queen`s University Kingston Ontario
Canada Hospital for Sick Children Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
The Hospital for Sick Children

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Neuronal responses during pro/anti-saccade eye movements Video-based eye tracking monocularly in the MEG and binocularly outside the MEG 60 minutes
Primary Electrical potentials initiated by brief visual stimuli Visual Evoked Potentials (VEP) 10 minutes
Primary MRI scans of the brain, including Diffusion Tensor Imagine (DTI) 90 minutes
Primary Neurocognitive Testing Computerized Penn Neurocognitive Battery 90 minutes
Primary High contrast visual acuity 10 minutes
Primary Low contrast visual acuity; colour vision; visual fields testing; OCT testing; 10 minutes
Primary Colour vision testing 10 minutes
Primary Visual fields testing 20 minutes
Primary Optical coherence tomography (OCT) 25 minutes
Primary Neurological Exam - Standard physical exam performed by neurologist to determine the Expanded Disability Status Scale (EDSS) score. 20 minutes
Primary Clinical Interview 10 minutes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04997343 - Neurophysiological Assessment in Patients With Multiple Sclerosis N/A
Completed NCT00001780 - Magnetic Stimulation of the Human Nervous System N/A